Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kinerase Pro+Therapy (Janssen Pharmaceutical)
- Development stage
- Unknown
- Lead developer
- Janssen Pharmaceutical
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Kinerase Pro+Therapy is a professional-grade cosmeceutical skincare regimen developed by Innovative Medical for addressing the visible signs of skin aging and photo-damage. The product line is formulated with two primary plant-based cytokinins: kinetin (N6-furfuryladenine) and zeatin. These small molecules function as potent antioxidants and growth factors that help delay cellular senescence and improve the skin's barrier function. By protecting against oxidative stress and promoting cellular health, the regimen aims to reduce the appearance of fine lines, wrinkles, and hyperpigmentation. The product line typically includes a variety of topical formulations such as day repair creams, serums, and night repair treatments. Although evaluated in Phase 4 clinical trials, the specific study comparing the regimen to single-agent Kinerase and controls was terminated.
- Brand names
- Kinerase Pro+Therapy
- Other names
- Kinerase Pro+Therapy LineKinerase Pro+Therapy regimen
02
Targets
DNA
Beyond the preview
Go deeper on Kinerase Pro+Therapy (Janssen Pharmaceutical).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kinerase Pro+Therapy (Janssen Pharmaceutical).